Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

The issue came up for discussions during the visit of Commerce Secretary Rajesh Agarwal to Buenos Aires this week.

Argentina has committed to reduce barriers to facilitate the entry of the Indian pharmaceutical sector into the South American nation, the Commerce Ministry said on Saturday (August 29, 2026).

This is expected to provide greater opportunities for Indian pharmaceutical companies and contribute to improving access to quality and affordable healthcare in Argentina, it said.

PM Modi, Argentine President Milei agree to diversify bilateral trade basket

“Argentina has committed to work towards upgrading India from Annex II to Annex I under its pharmaceutical regulatory framework and reducing barriers to entry,” it added.

The issue came up for discussions during the visit of Commerce Secretary Rajesh Agarwal to Buenos Aires this week.

He was in the country for the India-Argentina Joint Trade Committee (JTC), which was held on August 24, 2026 at Palacio San Martín, Buenos Aires.

Bilateral trade between India and Argentina crossed USD 6.5 billion in 2025, registering consistent annual growth of over 17%.

Investment opportunities across mining, energy and infrastructure were also discussed, including the continued engagement of India’s KABIL in Argentina’s lithium sector.

India and Argentina sign social security agreement for professionals

KABIL’s mining activities in Catamarca, the first lithium mining initiative by an Indian company in Argentina, have progressed significantly with the completion of Phase II drilling, it said.

It added that emerging areas of cooperation, including aviation, space technology, telecommunications and digital services, were identified as areas offering further opportunities for both countries, particularly in 5G, artificial intelligence and digital infrastructure.

The visit was also important as India and Mercosure bloc are looking to expand the existing preferential trade agreement.

Mercosur is a trade bloc in Latin America comprising Brazil, Argentina, Uruguay, and Paraguay. The India-Mercosur PTA came into effect on June 1, 2009.

Progress on the Terms of Reference, along with the adoption of digital certificates of origin, is expected to facilitate trade and make cross-border commerce more efficient for businesses, it said.

  • Related Posts

    Apollo Navi Mumbai launches geriatric oncology clinic

    With a dedicated Geriatric Oncology Clinic, Apollo Hospitals Navi Mumbai brings specialised geriatric cancer care to the private healthcare setting in Navi Mumbai. With the launch of the Geriatric Oncology…

    Maharashtra FDA cancels licences of 62 pharma units, 141 chemist shops

    Mumbai: The Food and Drug Administration (FDA) has cracked down on medical stores violating drug-sale rules, suspending 599 licences and cancelling another 141 after inspecting 2,295 retail establishments across the…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Apollo Navi Mumbai launches geriatric oncology clinic

    Apollo Navi Mumbai launches geriatric oncology clinic

    Maharashtra FDA cancels licences of 62 pharma units, 141 chemist shops

    Maharashtra FDA cancels licences of 62 pharma units, 141 chemist shops

    Himachal DCA honoured with ‘Regulatory Excellence Award’ at iPHEX 2026

    Himachal DCA honoured with ‘Regulatory Excellence Award’ at iPHEX 2026

    Baddi pharma firm loses licence after 1,200-kg tapentadol haul

    Baddi pharma firm loses licence after 1,200-kg tapentadol haul

    US FDA takes steps to maintain newborn access to life-saving starter nutrition products

    US FDA takes steps to maintain newborn access to life-saving starter nutrition products

    Mankind Pharma launches campaign to inspire 1 crore Indians to pledge for organ donation